HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.

AbstractBACKGROUND:
Epigenetic alterations, such as histone methylation, modulate Myc signaling, a pathway central to oncogenesis. We investigated the role of the histone demethylase KDM4B in N-Myc-mediated neuroblastoma pathogenesis.
METHODS:
Spearman correlation was performed to correlate MYCN and KDM4B expression. RNA interference, microarray analysis, gene set enrichment analysis, and real-time polymerase chain reaction were used to define the functions of KDM4B. Immunoprecipitation and immunofluorescence were used to assess protein-protein interactions between N-Myc and KDM4B. Chromatin immunoprecipitation was used to assess the binding of Myc targets. Constitutive and inducible lentiviral-mediated KDM4B knockdown with shRNA was used to assess the effects on tumor growth. Kaplan-Meier survival analysis was used to assess the prognostic value of KDM4B expression. All statistical tests were two-sided.
RESULTS:
KDM4B and MYCN expression were found to be statistically significantly correlated in a variety of cancers, including neuroblastoma (R = 0.396, P < .001). Functional studies demonstrated that KDM4B regulates the Myc pathway. N-Myc was found to physically interact with and recruit KDM4B. KDM4B was found to regulate neuroblastoma cell proliferation and differentiation in vitro and xenograft growth in vivo (5 mice/group, two-tailed t test, P ≤ 0.001). Finally, together with MYCN amplification, KDM4B was found to stratify a subgroup of poor-prognosis patients (122 case patients, P < .001).
CONCLUSIONS:
Our findings provide insight into the epigenetic regulation of Myc via histone demethylation and proof-of-concept for inhibition of histone demethylases to target Myc signaling in cancers such as neuroblastoma.
AuthorsJun Yang, Alaa M AlTahan, Dongli Hu, Yingdi Wang, Pei-Hsin Cheng, Christopher L Morton, Chunxu Qu, Amit C Nathwani, Jason M Shohet, Theodore Fotsis, Jan Koster, Rogier Versteeg, Hitoshi Okada, Adrian L Harris, Andrew M Davidoff
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 107 Issue 6 Pg. djv080 (Jun 2015) ISSN: 1460-2105 [Electronic] United States
PMID25925418 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: [email protected].
Chemical References
  • MYC protein, human
  • Proto-Oncogene Proteins c-myc
  • Jumonji Domain-Containing Histone Demethylases
  • KDM4B protein, human
Topics
  • Animals
  • Cell Differentiation
  • Cell Line, Tumor
  • Cell Proliferation
  • Chromatin Immunoprecipitation
  • DNA Methylation
  • Gene Expression Regulation, Neoplastic
  • Heterografts
  • Humans
  • Jumonji Domain-Containing Histone Demethylases (metabolism)
  • Kaplan-Meier Estimate
  • Mice
  • Neuroblastoma (genetics, metabolism)
  • Prognosis
  • Protein Array Analysis
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Real-Time Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: